KateMurray

About Kate Murray

This author has not yet filled in any details.
So far Kate Murray has created 68 blog entries.

Nutrition and Specific Mito Disorders

As mitochondrial disease represents over 350 different diagnoses, it makes sense that nutrition can play different roles depending on the underlying condition.

In some disorders, nutrition strategies are focused on preventing metabolic crisis; in others, the goal may be to reduce catabolic stress, support muscle health, or complement diagnosis-specific therapies. Broad clinical care standards emphasize individualized planning and avoiding metabolic stressors (like prolonged fasting), with diagnosis-specific guidance helping further shape nutrition approaches.

For FAOD, nutrition is often a central part of disease management. Because the body many not be able to use fats effectively for energy, maintaining a reliable fuel supply (often emphasizing carbohydrates) and avoiding fasting is critical. Clinical and guideline literature repeatedly highlights:

MELAS can involve high metabolic demand and multi-system symptoms (including GI and nutrition challenges), so nutrition strategies often emphasize maintaining energy balance and preventing catabolic stress during illness or poor intake.

Targeted supplementation is sometimes discussed in MELAS, most notably arginine and/or citrulline in relation to stroke-like episodes. The literature includes supportive reports and reviews, but consensus guidance also notes limitations and ongoing debate about strength of evidence and clinical use.

In MELAS, nutrition care often focuses on steady intake, illness-day planning, and discussing targeted therapies (like specific supplements) with a mitochondrial specialist because recommendations vary across clinics and individuals.

When muscle involvement is prominent, nutrition strategies often focus on supporting muscle maintenance and minimizing fatigue by ensuring adequate overall calories and protein, especially if appetite is low or unintentional weight loss is present.

Some research in mitochondrial disease populations (including those with muscle symptoms) suggests that insufficient intake is common, and that higher intakes of macronutrients (including protein) may correspond with better outcomes like muscle strength, lower fatigue, and improved quality of life, though this doesn’t mean “more is always better,” and personalization matters.

For mitochondrial myopathies, nutrition support often prioritizes “enough energy + enough protein,” using practical strategies (small frequent meals, energy-dense additions, smoothies) when fatigue or GI issues make intake difficult.

POLG-related disorders can present very differently from one person to another. Nutrition strategies commonly emphasize preventing catabolic stress (especially during illness or reduced intake) and maintaining consistent energy availability, an approach aligned with broader mitochondrial care standards.

In some POLG-related conditions, seizures can be a major concern, and dietary therapies (such as ketogenic-style approaches) may be considered in specialized contexts (typically for difficult-to-treat refractory epilepsy) under expert supervision, with careful monitoring and individualized risk–benefit discussions.

For POLG, the key nutrition themes are often “avoid catabolic stress, plan for illness, and create individualize dietary approaches with your mito specialist and care team,” especially if seizures or significant GI/nutrition issues are part of the picture.

Because mitochondrial disease includes many different conditions, nutrition approaches are rarely one-size-fits-all. Some disorders rely heavily on nutrition strategies to prevent metabolic crisis, while others focus on maintaining energy balance, supporting muscle health, or managing symptoms. Across many diagnoses, maintaining consistent energy intake and avoiding metabolic stress are key themes. Individualized guidance from a mitochondrial specialist or dietitian is important to determine the best approach.

Fasting and Mito

Fasting can significantly change how the body fuels itself. When you go without food for longer periods, the body shifts away from using incoming carbohydrates and begins relying more on stored fuels (including fats, protein/muscle). For individuals living with mito, where energy production may already be less efficient, this shift can add metabolic stress and may worsen symptoms for some individuals.

Clinical care standards for mitochondrial disease specifically emphasize preventing catabolism (a state where the body breaks down stored energy and tissue) and recommend avoiding prolonged fasting, particularly around illness, procedures or other stressors.

Because mitochondrial disorders are highly variable, always consult the specialist overseeing your mitochondrial disease care before trying fasting, intermittent fasting or any restrictive eating approach. The “right” strategy must match the diagnosis and the individual, not what is trending online.

The Mito Cocktail

Some mitochondrial specialists may recommend a combination of vitamins and mitochondrial cofactors (nutrients that help enzymes do their jobs), often referred to as the mito cocktail. The goal of a mito cocktail is supportive, to help optimize mitochondrial function, reduce metabolic stress, and improve symptom management.

It’s important to know that there is no single standard mito cocktail. Supplement choices (if recommended at all) depend on an individual’s diagnosis, symptoms, age, medications and lab findings. Clinical experts emphasize that while strong randomized trial evidence is limited for many supplements, supplements are often used in practice because some have biologic rationale, relatively favourable safety profiles when monitored, and may be particularly relevant in specific mito conditions.

Specialists may consider supplements because they can help:

  • Support energy production pathways (including oxidative phosphorylation)
  • Provide cofactors needed for mitochondrial enzymes
  • Help manage secondary effects of mitochondrial dysfunction (like oxidative stress)
  • Address suspected or documented nutrient deficiencies

In some mitochondrial disorders, specific supplements are more commonly considered because of the underlying biology. For example, the Mitochondrial Medicine Society care standards note that riboflavin may be considered in ACAD9-related myopathy and that a combination of CoQ10 and riboflavin may be considered for ETFDH gene-related myopathy.

These are often discussed during mito clinc appointments and in patient resources, but not everyone needs them, and dosing/selection should be individualized.

There’s a fair amount of supplement information online that can sound very convincing. But with mitochondrial disease, the right supplement plan depends on the type of diagnosis and the right clinical context. Supplements can interact with medications, affect lab test results and, depending on the individual, may cause side effects.

Before starting, stopping or changing any supplement, it’s strongly recommended that you discuss it with the specialist overseeing your mitochondrial disease care.

Mealtime Approaches to Managing Energy Levels

Energy conservation is an important part of daily living with mito. Because energy production may be limited, everyday activities such as planning, preparing and eating meals can contribute to fatigue.

Mealtime strategies that reduce physical and cognitive effort can help preserve energy for other essential activities while still supporting consistent nutrition. Small adjustments in how and when meals are prepared and eaten make a meaningful difference.

1. Planning meals in advance
Deciding what to eat ahead of time can reduce decision fatigue and help avoid missed meals on lower-energy days. Simple meal plans or rotating familiar meals can support consistency without added stress

2. Sitting while preparing food
Sitting during food prep helps conserve energy, reduces muscle strain, and support safety, especially for individuals with muscle weakness, balance challenges or fatigue.

3. Using convenience options, when needed
Pre-cut produce, frozen meals, canned food, slow cooker and delivery options can be helpful tools, not shortcuts. These options can help maintain nutrition on days when energy is limited.

4. Timing larger meals during periods of higher energy
Eating more substantial meals at times of day when energy is typically better may help reduce fatigue and support digestion. Lighter meals or snacks may feel more manageable during lower-energy periods.

Care partners play a valuable role in supporting consistent nutrition, particularly during periods of illness, increased fatigue, or symptom flare-ups. Assistance with meal preparation, reminders to eat or drink, and flexibility around mealtime expectations can help reduce pressure and support overall well-being.

Managing Food Triggers in Mito

Food-related symptom flare-ups have been a reported experience for some individuals living with mito. Because mito can affect multiple organ systems, including the gastrointestinal tract, muscles, nervous system and autonomic nervous system, responses to food, meal timing and portion size can vary widely from person to person.

Research and clinical care guidelines increasingly recognize that metabolic stress, including prolonged fasting, large energy demands from digestion or rapid shifts in blood sugar, may worsen symptoms in individuals with impaired mitochondrial energy production. Patient reports also highlight that certain foods or eating patterns can contribute to fatigue, gastrointestinal discomfort, headaches, muscle pain or symptom flares.

Commonly reported triggers may include:

  • Skipping meals or prolonged fasting, which can increase metabolic stress and reduce available energy, particularly important for individuals who rely heavily on regular carbohydrate intake
  • Large, heavy meals, which may be more difficult to digest and can temporarily increase fatigue or gastrointestinal symptoms
  • Highly processed foods, which may be lower in essential nutrients and harder for someone individuals to tolerate
  • Excessive caffeine or alcohol, which can affect hydration, sleep, heart rate and nervous system regulation, potentially worsening symptoms in some people.

It’s important to note that these are not universal triggers. Foods or patterns that cause symptoms for one individual may be well tolerated by another.

Keeping a food-and-symptom journal can be a helpful, low-pressure way to notice patterns over time. Recording what is eaten, when meals occur, portion size, and how symptoms change afterward may help individuals and their healthcare providers identify potential triggers and make thoughtful adjustments.

When symptom flare-ups are frequent, severe, or associated with weight loss, dehydration, or declining function, it’s important to discuss these changes with a healthcare provider. Dietitians and mitochondrial specialists can help distinguish food-related triggers from other causes and support safe, individualized nutrition strategies.

Strategies to Enhance Energy Intake

Meeting energy needs can be challenging for some individuals living with mito. Reduced appetite, feeling full quickly (early satiety), nausea, gastrointestinal discomfort, or fatigue related to meal or food preparation can all make it difficult to eat enough to meet the body’s energy demands. Because energy-producing pathways may be less efficient in mito, even small shortfalls in intake can contribute to increased fatigue or symptom flare-ups over time.

The goal of nutrition strategies is to support steady, realistic energy intake while minimizing additional strain on the body.

  • Eating small, frequent meals rather than large portions, which may feel more manageable and help maintain consistent availability throughout the day.t
  • Choosing energy-dense foods (such as nut butters, avocado, olive oil or full-fat dairy, if tolerated) to provide more calories and nutrients in smaller volumes.
  • Adding healthy fats to meals to increase energy intake without significantly increasing portion size
  • Using smoothies, soups or oral nutrition supplements when solid foods are difficult to tolerate or appetite is low

Because nutritional needs and tolerances can vary widely depending on the specific mitochondri diagnosis, symptoms, and overall health, working with a healthcare provider or dietitian familiar with mitochondrial disease can help tailor these strategies. Personalized guidance can be especially important during periods of illness, stress or unintentional weight loss, when energy needs may change.

Hydration for Energy Support

Adequate hydration is an essential component of nutrition and plays a critical role in how the body produces and uses energy. Water is necessary for circulation, digestion, temperature regulation, and cellular metabolism, all processes that are already under increases strain in mitochondrial disease.

At the cellular level, hydration supports the movement of nutrients, electrolytes, and metabolic by-products in and out of the cells. When fluid levels are low, these processes become less efficient, which can further challenge energy production and worsen symptoms.

For individuals living with mito, even mild dehydration may contribute to increased fatigue, dizziness, headaches, constipation, muscle cramps and difficulty regulating body temperature, symptoms commonly reported across many mitochondrial conditions. Dehydration can also place additional stress on the cardiovascular and nervous systems, which may already be affected.

Consider the folowing:

  • Sip fluids regularly throughout the day, rather than drinking large amounts at once, to support steady absorption and avoid sudden fluid shifts
  • Include water-rich foods such as soups, fruits, and vegetables, which can contribute to daily fluid intake
  • Consider electrolyte-containing fluids, if recommended by a healthcare provider, especially during illness, hot weather, or periods of increased physical stress.

Individual fluid needs vary. Individuals with cardiac involvement, kidney disease, gastrointestinal symptoms or autonomic dysfunction (e.g., dizziness, temperature regulation, feeling faint, headaches) may require more personalized hydration strategies. Always speak with a healthcare provider before making significant changes to fluid or electrolyte intake.

Building a Well-Balanced, Nutrient-Dense Diet

A well-balanced diet provides a steady supply of fuel and essential nutrients that cells rely on to produce energy and maintain cellular function. In mitochondrial disease, where energy-producing pathways may be less efficient, consistent access to high-quality nutrition becomes especially important.

Rather than relying on one primary fuel source, a balanced approach supports multiple energy pathways and helps reduce metabolic stress on the body. Nutrient-dense foods, those that provide vitamins, minerals and energy without excessive calories, can help support energy levels, muscle function, and overall resilience.

1. Regular meals and snacks
Eating at consistent intervals helps maintain stable energy availability and may reduce fatigue, dizziness or symptom flare-ups associated with low energy stores.

2. Complex carbohydrates
These are foods that digest more slowly, providing a steady release of glucose, and longer-lasting energy, which many cells rely on for energy. They also help avoid rapid spikes and drops in sugar.

3. High-quality proteins
Provide essential amino acids that supports muscle maintenance, tissue repair and immune function. Adequate protein intake is important for preserving strength, especially for individuals with muscle involvement.

4. Healthy fats

Fats provide a concentrated source of energy and support the absorption of fat-soluble vitamins. The ability to use fat for energy varies by mitochondrial diagnosis, so individual guidance from a healthcare provider is important.

Not all individuals with mitochondrial disease can use fats efficiently and recommendations may differ depending on diagnosis and symptoms.

Because the body relies on multiple fuels and interconnected energy-producing pathways to generate ATP, maintaining a balanced intake of carbohydrates, proteins and fats is especially important in mitochondrial disease. When one or more of these pathways is less efficient, the body benefits from having flexible access to different sources.

For this reason, highly restrictive diets are generally discouraged unless they are medically indicated and supervised by a healthcare professional. Limiting entire food groups may increase the risk of nutrient deficiencies and can place additional strain on already challenged energy systems, potentially worsening fatigue and other symptoms.

The Role of Nutrition in Mitochondrial Disease

Nutrition refers to the process of taking in food and fluids to provide the body with energy, support growth, and repair and maintain overall health. Nutriton provides the raw materials mitochondria need to produce energy.

When we eat carbohydrates, they are broken down by digestive enzymes into glucose, fats are broken down by bile from the liver and digestive enzymes into fatty acids, and the protein we eat are broken down by digestive enzymes into amino acids.

Glucose, fatty acids and amino acids (smaller building blocks) are absorbed into the bloodstream and then taken up by muscle, brain and nerve, heart, and liver cells among others.

Inside the cells, mitochondria act as energy factories, using these fuel sources to produce ATP (adenosine triphosphate), the body’s main source of energy.

Energy problems can arise for a number of reasons in mitochondrial disease. Some disorders affect different energy-producing pathways, depending on the underlying genetic cause. Some individuals have difficulty using carbohydrates efficiently, others may struggle to use fats for energy, and some may be affected by multiple pathways.

Understanding which energy pathways are impacted can help explain why certain nutrition strategies are recommended for specific mitochondrial disorders.

Carbohydrate-Based Energy Pathways

What happens: Glucose is processed and ultimately used by mitochondria to create ATP

When this pathway is impaired:

  • The body has difficulty using glucose efficiently for energy, which can lead to energy drops and make the body more reliant on other energy pathways to produce energy.

Fat-Based Energy Pathways

What happens: Fatty acids are transported into mitochondria and broken down to create ATP

When this pathway is impaired:

  • There’s difficulty using fatty acids as a fuel source, which increases reliance on carbohydrates as a backup. During times illness, fasting or missed meals, the body is more likely to run out of usable energy.

* Oxidative Phosphorylation is the pathway impaired in fatty acid oxidation disorders (FAOD)

Protein-Based Energy Pathways

What happens: Some amino acids can be used to support energy production, when needed

When this pathway is impaired:

  • The body has more difficulty using amino acids for backup energy, which can increase fatigue and place extra strain or workload on other energy systems to compensate.

* Protein (amino acid) is not the body’s preferred fuel source because it’s more complex to breakdown, creating more metabolic stress or making cells in the body work harder to create needed energy.

In mitochondrial disease, any of the above energy-producing pathways may be inefficient or impaired. As a result, individuals may experience fatigue, muscle weakness, exercise intolerance, gastrointestinal symptoms, and difficulties maintaining weight or energy balance.

Thoughtful nutrition strategies can help:

  • Support more stable energy production
  • Reduce metabolic stress
  • Prevent nutrient deficiencies
  • Manage symptoms such as fatigue, nausea, and muscle pain

While nutrition is not a cure for mitochondrial disease, it can be a key component of comprehensive care.

Dr. Carlos T. Moraes

Launching a New Era in Mitochondrial Gene Editing

From his early days studying science to decades of dedicated research in mitochondrial DNA and gene therapy, Dr. Carlos T. Moraes has made an indelible mark in his field.

After studying biomedicine and molecular biology in São Paulo, Brazil, where he was born and raised, a young Carlos jumped at an opportunity to connect with an esteemed neurologist, an expert in neuromuscular diseases including mitochondrial disease, in New York. Shortly after arriving and completing a stint of training with the neurologist, he decided to pursue a PhD at New York City’s Columbia University.

“This was back in the late ’80s and early ’90s, and it was a pretty exciting time,” says Dr. Moraes. “Mutations in mitochondrial DNA (mtDNA) were just being reported for the first time. The neurologist I was studying under (Dr. Salvatore DiMauro) had many muscle biopsies that we could analyze, and one of the first things we did was correlate certain mutations with certain disease phenotypes. One paper we published early on was about how large deletions in mtDNA were almost always found in patients who have Kearns-Sayre syndrome, a rare neuromuscular disorder.”

As more mutations were reported, the field of mitochondrial genetics exploded. Dr. Moraes completed his studies in New York and took a research facility position at the University of Miami in 1994, where he remains a prominent professor in the Department of Neurology at the Miller School of Medicine. “I continued to study mtDNA problems, not only in disease but also in aging,” he says, “with mtDNA always being at the core of it.”

Sometimes happenstance brings about the most meaningful paths. “I started working on mitochondrial diseases by pure chance, but the more I worked on it, the more I fell in love with it,” says Dr. Moraes. “The mitochondrion is like a battery inside the cell, and it has its own DNA. It’s the only organelle besides the nucleus that does. It’s a fascinating system, and so I’ve devoted my career to it.”

Dr. Moraes was also driven by a desire to help patients living with mitochondrial disease. “I’m not an MD, but very early on I was touched by the lack of treatments these patients had,” he says. “That was extra motivation to work more and more toward therapy.”

Continuing his research, Dr. Moraes and his colleagues found that a specific genetic mutation, usually responsible for mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes (MELAS), also caused a variety of manifestations. “This mutation is one of the most common mtDNA mutations in the patient population,” he says. “In 1993, we published research showing that patients with this mutation could have many different types of diseases and many different symptoms, and that these symptoms clustered within families, suggesting that nuclear DNA plays a role in modifying how the mtDNA mutation shows up.”

Building on this research, Dr. Moraes conducted an evolutionary compatibility experiment. “We took mtDNA from different types of primates and put it into cells with human nuclear DNA to see if they could produce energy,” he says. “The only mtDNA that could coexist with human nuclei was from chimpanzees and gorillas.” Even an orangutan’s mtDNA wouldn’t work. “They co-evolved with enough difference that they cannot work together,” explains Dr. Moraes. The experiment showed how closely mtDNA and nuclear DNA must work together, and how that relationship was shaped by millions of years of evolution.

In the last two decades, Dr. Moraes’ research has focused more and more on gene therapy and on pioneering mtDNA gene editing techniques. “One thing I’m known for is using enzymes that cut mtDNA as a form of therapy,” he says. “In the lab, we use these enzymes called restriction enzymes. They recognize a short sequence in the mtDNA and cut it. They’re very specific. They cut only on this sequence. This was in the early 2000s.”

Further research and genetic engineering demonstrated that when mutant mtDNA was targeted and cut, the remaining healthy mtDNA would take over. “We showed that once we cut the mtDNA, it’s very quickly degraded, and whatever’s left replicates to make up for the loss,” says Dr. Moraes.

The restriction enzymes were limited, however. While they were capable of cutting out mutant mtDNA, “there aren’t many disease mutations that create restriction sites for these enzymes,” says Dr. Moraes. “We were always thinking, if only there was an enzyme that didn’t only recognize such small sequences, but also bigger ones. If only there was a way we could control this enzyme.” They needed something programmable.

“Our dreams came true around 2010, when gene editing enzymes were first described,” says Dr. Moraes. “They could be engineered to recognize long, specific sequences, and more importantly, you could design what kind of sequence you wanted them to recognize.”

These new protein-based gene editors changed the game, allowing scientists to target almost any DNA sequence. “That was a major breakthrough that allowed us to eliminate mutant mtDNA in a very specific way,” says Dr. Moraes. “And again, as the mutant mtDNA was cut, the normal mtDNA that was left would replicate to make up for the lack of mtDNA quantity. This would change the cell, causing it to behave better and to produce more energy.”

Next, Dr. Moraes and his team started collaborating with Precision BioSciences, a company that had developed novel gene editing enzymes called ARCUS and mitoARCUS. These enzymes were smaller and easier to deliver to the cell. “We continue to collaborate to this day,” says Dr. Moraes.“They’re now trying to perform a clinical trial on mitoARCUS that’s specific to the mutation that’s usually associated with MELAS, but also associated with exercise intolerance and other symptoms like hearing loss, diabetes, and migraines.”

In 2020, researchers discovered mitochondrial base editors, which can change a single letter of mtDNA without cutting. “They’re called base editors because they edit the DNA,” says Dr. Moraes. “A base editor that works in the mtDNA was able to change a C to a T in the DNA code. It was very limited, but it was the first step. For the first time, we could change mtDNA without having to cut.”

Expanding on this research, Dr. Moraes and his lab used one of the base editors to rescue mitochondrial function in a mouse model. “We found a way to base edit a gene with a pathogenic mutation so that it became stable, improving the function of the mitochondrial energy production in the mouse model,” he says.

Those familiar with the gene editing technology CRISPR may wonder why it’s not part of the story here. “I’m always asked why we can’t use CRISPR to cut or edit mtDNA,” says Dr. Moraes. “CRISPR needs a guide RNA, and we don’t know how to make RNA go to mitochondria, so it won’t work.”

While both nuclear gene therapy and mtDNA editing have advanced greatly, Dr. Moraes notes that the main limitation is the difficulty of getting the gene editing tools into the cells that need them. Progress continues to be made; however,  scientists push forward with new strategies to overcome these delivery challenges.

“If you reduce mutant mtDNA below a certain threshold that makes a patient sick, you’re essentially curing the disease,” says Dr. Moraes. “So this is potentially curative.”

He also notes the exciting potential of a one-and-done solution. “If you reduce this mutant mtDNA enough, probably you don’t have to do it again,” he says. This is in contrast to nuclear gene therapies, as are used for Duchenne muscular dystrophy, for example, where the treatment effect can diminish over time and repeat dosing is challenging.

Dr. Moraes loves working with students, trainees, and technicians, describing his work as exciting and rewarding. “I love everything about it,” he says. “And it goes without saying that if we can find something that can help patients, that’s at the top of the list of the rewards we’re looking for.”

The motivation to continue developing these therapies and finding treatments or a cure is strong. Dr. Moraes encourages the next generations of researchers to have a thick skin and to be tenacious. “We have to keep pushing,” he says. “There are lots of failures in this field, but a failure isn’t a total failure if you understand why the experiment didn’t work. It always teaches you something.”

With the field of gene therapy exploding, Dr. Moraes is extremely optimistic about the future, mentioning that he expects that a major gene therapy breakthrough is “just around the corner.”

He’s pleased to share his research with the MitoCommunity as well. “It’s very important for science not to live in a silo, isolated from the community that it’s trying to help,” he says. “The MitoCommunity needs information, and to help us keep doing our work. Research is a very expensive business, unfortunately, and it cannot be done without funding. We need patients, families, and scientists working together to keep the field moving forward.”

© MitoCanada 2025. Shared with permission. Not for reuse or adaptation without consent.

Go to Top